YU47077B - Postupak za izradu transdermalnog terapijskog sistema sa fizostigminom kao aktivnim sastojkom - Google Patents
Postupak za izradu transdermalnog terapijskog sistema sa fizostigminom kao aktivnim sastojkomInfo
- Publication number
- YU47077B YU47077B YU240789A YU240789A YU47077B YU 47077 B YU47077 B YU 47077B YU 240789 A YU240789 A YU 240789A YU 240789 A YU240789 A YU 240789A YU 47077 B YU47077 B YU 47077B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- active ingredient
- therapeutic system
- transdermal therapeutic
- weight
- physostigmin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
POSTUPAK ZA IZRADU TRANSDERMALNOG TERAPIJSKOG SISTEMA SA FIZOSTIGMINOM KAO AKTIVNIM SASTOJKOM, sloja rezervoara koji se lepeći prijanja i u datom slučaju zaštitnog sloja ponovo odvojivog, naznačen time, što se aktivna materija fizostigmin u datom slučaju u rezervoaru zajedno homogeno pomeša sa sastojcima sloja rezervoara koji se lepi prijanjajući i nanese na pokrivni sloj nepropusan za aktivnu materiju, u datom slučaju odstrani rastvarač i sloj rezervoara koji se lepi pokriva sa zaštitnim sloje, pri čemu sloj rezervoara sadrži 10-90 mas.- % polimernog materijala, odabranog iz grupe koja se sastoji iz blok polimera na bazi stirolai 1,3-diena, poliizobutilena, polimera na bazi akrilata i/ili metakrilata i estara hidrogenovanog kolofonijuma, 0-30 mas. - % omekšivača i 0,1-20 mas. - % fizostigmina. Prijava sadrži još 1 nezavisan i 13 zavisnih zahteva.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI8912407A SI8912407B (sl) | 1988-12-22 | 1989-12-19 | Postopek za izdelavo transdermalnega terapevtskega sistema z fizostigminom kot dejavno sestavino |
HR930669A HRP930669B1 (en) | 1988-12-22 | 1993-04-01 | Transdermal therapeutic system having physostigmine as the active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3843239A DE3843239C1 (sh) | 1988-12-22 | 1988-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU240789A YU240789A (en) | 1991-04-30 |
YU47077B true YU47077B (sh) | 1994-12-28 |
Family
ID=6369855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU240789A YU47077B (sh) | 1988-12-22 | 1989-12-19 | Postupak za izradu transdermalnog terapijskog sistema sa fizostigminom kao aktivnim sastojkom |
Country Status (29)
Country | Link |
---|---|
US (1) | US5089267A (sh) |
EP (1) | EP0376067B1 (sh) |
JP (1) | JPH0784379B2 (sh) |
KR (1) | KR950015058B1 (sh) |
CN (1) | CN1045355A (sh) |
AT (1) | ATE105488T1 (sh) |
AU (1) | AU614209B2 (sh) |
CA (1) | CA2006404C (sh) |
CS (1) | CS277066B6 (sh) |
DD (1) | DD290580A5 (sh) |
DE (2) | DE3843239C1 (sh) |
DK (1) | DK651289A (sh) |
ES (1) | ES2056185T3 (sh) |
FI (1) | FI95775C (sh) |
GE (1) | GEP19960440B (sh) |
HU (1) | HU205252B (sh) |
IE (1) | IE64200B1 (sh) |
IL (1) | IL92680A (sh) |
LT (1) | LT3785B (sh) |
MY (1) | MY104491A (sh) |
NO (1) | NO180072C (sh) |
NZ (1) | NZ231907A (sh) |
PH (1) | PH25853A (sh) |
PL (1) | PL162690B1 (sh) |
PT (1) | PT92652B (sh) |
RU (1) | RU2011384C1 (sh) |
UA (1) | UA18868A (sh) |
YU (1) | YU47077B (sh) |
ZA (1) | ZA899878B (sh) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3843238C1 (sh) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
US5241925A (en) * | 1988-12-27 | 1993-09-07 | Dermamed | Apparatus and techniques for administering veterinary medicaments |
US5332577A (en) * | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
US5324521A (en) * | 1989-12-18 | 1994-06-28 | Dermamed | Systems for transdermal administration of medicaments |
NZ237241A (en) * | 1990-03-02 | 1993-11-25 | Pharmetrix Corp | Method for increasing the storage stability of physostigmine |
DE4010079A1 (de) * | 1990-03-29 | 1991-10-02 | Lohmann Therapie Syst Lts | Pharmazeutische formulierung zur behandlung des alkoholismus |
WO1991015176A1 (en) * | 1990-04-06 | 1991-10-17 | Pharmetrix Corporation | Device and method for enhanced administration of physostigmine |
DE4020144A1 (de) * | 1990-06-25 | 1992-01-09 | Lohmann Therapie Syst Lts | Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen |
DE4238223C1 (de) * | 1992-11-12 | 1994-05-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung |
US5409948A (en) * | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
DE4301783C1 (de) * | 1993-01-23 | 1994-02-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil |
DE4301782C1 (de) * | 1993-01-23 | 1994-08-25 | Lohmann Therapie Syst Lts | Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit |
DE4342174C1 (de) | 1993-12-10 | 1995-05-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung |
DE4400770C1 (de) * | 1994-01-13 | 1995-02-02 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung |
JP3947564B2 (ja) | 1994-10-28 | 2007-07-25 | キンバリー クラーク ワールドワイド インコーポレイテッド | 接着剤付き吸収性物品 |
TW304167B (sh) * | 1995-01-30 | 1997-05-01 | Lilly Co Eli | |
US5810960A (en) * | 1995-03-08 | 1998-09-22 | Nitto Denko Corporation | Paint film-protective sheet |
DE19706824C1 (de) * | 1997-02-21 | 1998-03-26 | Lohmann Therapie Syst Lts | Transdermales oder topisches Plastersystem mit Polyacrylatmatrix mit verbesserten physikalischen Eigenschaften |
DE19906979B4 (de) | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
DE10119862A1 (de) | 2001-04-24 | 2002-11-07 | Hf Arzneimittelforsch Gmbh | Verwendung von Galanthamin zur Behandlung von Krankheitserscheinungen des zentralen Nervensystems aufgrund von Intoxikationen mit psychotropen Substanzen |
DE10119863A1 (de) * | 2001-04-24 | 2002-11-07 | Hf Arzneimittelforsch Gmbh | Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen |
DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
DE10134038A1 (de) * | 2001-07-12 | 2003-02-06 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit |
DE10159745A1 (de) * | 2001-12-05 | 2003-07-03 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort |
MXPA05002254A (es) * | 2002-08-30 | 2005-06-08 | Alza Corp | Construccion de refuerzo multilaminar estampable y registrable. |
DE10318714B4 (de) * | 2003-04-25 | 2006-03-23 | Hf Arzneimittelforschung Gmbh | Wirkstoff-Kombinationen und Therapien zur Bekämpfung des Alkoholmissbrauches |
US20050182044A1 (en) * | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
AT500143A1 (de) * | 2004-04-22 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung |
CA2508585A1 (en) * | 2004-06-01 | 2005-12-01 | Axonyx, Inc. | Transdermal delivery system for treatment of cognitive disorders |
EP1604686A1 (en) * | 2004-06-08 | 2005-12-14 | Axonyx, Inc. | Use of phenserine and a HMG CoA reductase inhibitor for delaying Alzheimer's disease progression |
CN1320006C (zh) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | 包含酯基部分带酯基基团的丙烯酸酯的组合物 |
CN1326894C (zh) * | 2005-03-24 | 2007-07-18 | 上海交通大学 | 包含酯基部分带烷氧基的丙烯酸酯的组合物 |
CN1320008C (zh) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | 包含酯基部分带羧基基团的丙烯酸酯的组合物 |
CN1320009C (zh) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | 包含酯基部分带羟基基团的丙烯酸酯的组合物 |
CN1320005C (zh) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | 包含酯基部分带烷烃基的丙烯酸酯的组合物 |
CN1994290B (zh) * | 2006-01-04 | 2011-03-16 | 上海医药工业研究院 | 卡巴拉汀透皮贴剂及其制备方法 |
GB0809905D0 (en) * | 2008-06-02 | 2008-07-09 | Secr Defence | A Transdermal drug delivery device |
KR101317158B1 (ko) | 2011-02-18 | 2013-10-15 | 조선대학교산학협력단 | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
DE102019201431A1 (de) | 2019-02-05 | 2020-08-06 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System (TTS) mit Feststoffreservoir |
DE102019201430A1 (de) | 2019-02-05 | 2020-08-06 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System (TTS) mit Transportmedium |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US3921363A (en) | 1974-05-17 | 1975-11-25 | Preston Metal & Roofing Prod | Cross member with end connector |
JPS5620514A (en) * | 1979-07-27 | 1981-02-26 | Nitto Electric Ind Co Ltd | Plaster for remedy of skin disease |
JPS596285B2 (ja) * | 1980-09-22 | 1984-02-10 | 日東電工株式会社 | 外用部材 |
JPS57116011A (en) * | 1981-01-08 | 1982-07-19 | Nitto Electric Ind Co Ltd | Pharmaceutical preparation |
JPS6066758A (ja) * | 1983-09-21 | 1985-04-16 | 日東電工株式会社 | 医薬製剤 |
DE3344691A1 (de) * | 1983-12-10 | 1985-06-20 | Bayer Ag, 5090 Leverkusen | Wirkstoffabgasesysteme |
ATE42901T1 (de) * | 1984-03-05 | 1989-05-15 | Nitto Denko Corp | Haftendes arzneimittelpraeparat fuer perkutane absorption. |
IL72684A (en) * | 1984-08-14 | 1989-02-28 | Israel State | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
US4680172A (en) * | 1985-03-05 | 1987-07-14 | Ciba-Geigy Corporation | Devices and methods for treating memory impairment |
US4765985A (en) * | 1985-03-05 | 1988-08-23 | Ciba-Geigy Corporation | Devices and methods for treating memory impairment |
US4668506A (en) * | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
DE3629304A1 (de) * | 1986-08-28 | 1988-03-24 | Lohmann Gmbh & Co Kg | Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung |
US4911707A (en) * | 1987-02-13 | 1990-03-27 | Ciba-Geigy Corporation | Monolithic user-activated transdermal therapeutic system |
DE3743945A1 (de) * | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung |
DE3843238C1 (sh) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts |
-
1988
- 1988-12-22 DE DE3843239A patent/DE3843239C1/de not_active Expired - Lifetime
-
1989
- 1989-12-13 IL IL92680A patent/IL92680A/xx unknown
- 1989-12-14 MY MYPI89001753A patent/MY104491A/en unknown
- 1989-12-14 ES ES89123085T patent/ES2056185T3/es not_active Expired - Lifetime
- 1989-12-14 EP EP89123085A patent/EP0376067B1/de not_active Expired - Lifetime
- 1989-12-14 DE DE58907647T patent/DE58907647D1/de not_active Expired - Lifetime
- 1989-12-14 AT AT8989123085T patent/ATE105488T1/de not_active IP Right Cessation
- 1989-12-18 US US07/452,529 patent/US5089267A/en not_active Expired - Fee Related
- 1989-12-18 AU AU46845/89A patent/AU614209B2/en not_active Ceased
- 1989-12-19 YU YU240789A patent/YU47077B/sh unknown
- 1989-12-19 FI FI896099A patent/FI95775C/fi not_active IP Right Cessation
- 1989-12-19 CS CS897191A patent/CS277066B6/cs not_active IP Right Cessation
- 1989-12-19 IE IE407989A patent/IE64200B1/en not_active IP Right Cessation
- 1989-12-20 DK DK651289A patent/DK651289A/da not_active Application Discontinuation
- 1989-12-20 NZ NZ231907A patent/NZ231907A/xx unknown
- 1989-12-20 PH PH39751A patent/PH25853A/en unknown
- 1989-12-21 UA UA4742793A patent/UA18868A/uk unknown
- 1989-12-21 PT PT92652A patent/PT92652B/pt not_active IP Right Cessation
- 1989-12-21 RU SU894742793A patent/RU2011384C1/ru active
- 1989-12-21 CA CA002006404A patent/CA2006404C/en not_active Expired - Fee Related
- 1989-12-21 ZA ZA899878A patent/ZA899878B/xx unknown
- 1989-12-21 DD DD89336083A patent/DD290580A5/de not_active IP Right Cessation
- 1989-12-21 HU HU896713A patent/HU205252B/hu not_active IP Right Cessation
- 1989-12-21 NO NO895171A patent/NO180072C/no not_active IP Right Cessation
- 1989-12-22 CN CN89109818A patent/CN1045355A/zh active Pending
- 1989-12-22 KR KR1019890019756A patent/KR950015058B1/ko not_active IP Right Cessation
- 1989-12-22 PL PL28294989A patent/PL162690B1/pl unknown
- 1989-12-22 JP JP1331444A patent/JPH0784379B2/ja not_active Expired - Lifetime
-
1993
- 1993-09-17 GE GEAP19931588A patent/GEP19960440B/en unknown
-
1994
- 1994-01-31 LT LTIP1842A patent/LT3785B/lt not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU47077B (sh) | Postupak za izradu transdermalnog terapijskog sistema sa fizostigminom kao aktivnim sastojkom | |
YU47076B (sh) | Postupak za izradu transdermalnog terapijskog sistema sa fizostigminom kao aktivnim sastojkom | |
YU47075B (sh) | Postupak za izradu transdermalnog terapijskog sistema sa noepseudiefedrinom kao aktivnim sastojkom |